Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Report

Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Analysis By Product Type (Single-ventricular device and Biventricular device), By Application (Jugular vein, Right atrium, Femoral vein and others), 2014 To 2025

Format: PDF  |  Report ID: GVR4358

Extracorporeal Life Support Device is a form of extracorporeal support. Extracorporeal Life Support Devices assist in intensive care management of respiratory failure especially in adult patients.

The working principle of Extracorporeal Life Support is based on an external pump which drains the venous blood from the patient to a membrane oxygenator that is the artificial lung, where the blood is oxygenated and carbon dioxide is removed. The blood is then reverted to the circulation of the patient.

There are basically two forms of Extracorporeal Life Support namely veno-arterial and the other is veno-venous. The factors that drive the growth of the global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices market include increasing patient pool suffering from cardiovascular and cardiopulmonary diseases. These incidences demand the need for cardiopulmonary monitoring and treatment system such as Veno–venous extracorporeal life support devices.

In addition, the factors such as smoking, changing lifestyle, rising geriatric population, and increasing disposable income also attribute to the occurrence of cardiopulmonary diseases. Moreover, symptoms such as hypertension, chest pain, shortness in breath, etc. can cause serious health issues. In such conditions, the VV ECLS Devices can be helpful for the patients in order to sustain the body to standard level.

On the other hand, there are also factors that may hamper the growth of the market such as lack of awareness about Veno–venous extracorporeal life support devices in some region and also the cost of these devices may restraint the market. The global Veno-Venous Extracorporeal Life Support Devices market is classified on the basis of type of product, application, end-user, and geography. On the basis of type of product, the global VV ECLS Devices market is classified as single-ventricular device and biventricular device. On the basis of application, the global Veno-Venous Extracorporeal Life Support Devices market is classified as jugular vein, right atrium, femoral vein, and others. On the basis of end-user, the global Veno-Venous Extracorporeal Life Support Devices market is classified as hospitals, clinics, ambulatory surgical centres, cardiac catheterization laboratory, and others.

On the basis of geography, the global Veno-Venous Extracorporeal Life Support Devices market is classified as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan, Japan and Middle East and Africa.

The North American region comprises U.S., and Canada. Latin America region comprises Mexico, and Brazil. Western European region comprises Germany, Italy, England, Spain, France, and Nordic countries. The Eastern European region comprises Russia, Poland, and Rest of Eastern Europe. Asia Pacific Excluding Japan comprises China, India, ASEAN, Australia & New Zealand. The Middle East and Africa comprises GCC, S. Africa, N. Africa, and Rest of MEA.

In case of geographical region, North America dominates a major share of the global VV ECLS Devices market. The factors that attribute to the dominant share of North America is owed to increase in geriatric population, rising incidence of cardiopulmonary diseases, high demand for innovative products and government programs to spread awareness regarding the risk associated with cardiopulmonary diseases.

On the other hand, Asia Pacific region exhibits significant growth rates for Veno-Venous Extracorporeal Life Support Devices market due to the increasing aging population, rising occurrence of cardiovascular and cardiopulmonary diseases and also expanding awareness and high demand for these devices. 

Some of the prominent players that fuel the growth of the global Veno-Venous Extracorporeal Life Support Devices market include MAQUET Holding B. V. & Co. KG, MedosMedizintechnik AG, Sorin Group, Microport Scientific Corporation, Medtronic, Plc., Terumo Cardiovascular Systems Corporation, and Nipro Medical Corporation.

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $4,950
Multi User - $5,950
Library Access - $7,950

Buy Chapters or Sections

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA